Glenmark to stop sale of its pain killer in US
Glenmark to stop sale of its pain killer in US
New Delhi: Drug maker Glenmark Pharmaceuticals Ltd said on Wednesday it will stop selling its morphine sulfate drug in the US, complying with a warning by that country’s drugs regulator. “In compliance with the conditions of the warning letter, Glenmark will cease distribution of their morphine sulfate product line within the timelines indicated by the FDA," the company said in a statement.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!